![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Department of Medicine, Division of Gastroenterology & Hepatology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania (M.A.F.d.G., S.R.); and Laboratory of Pharmacology, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil (A.M.d.O.)
We evaluated the role of receptor desensitization, activation of AT2 receptors, and enzymatic degradation of angiotensin II (Ang II) by amino/neutral endopeptidases in rat anococcygeus smooth muscle (ASM) relaxation. Ang II (0.3 nM to 10 µM) produced contractions (Emax = 21.50 ± 5.73%) followed by passive relaxations (Emax reduced to 9.08 ± 2.55%). Contractions were inhibited (Emax = 13.67 ± 2.03%) by losartan (0.1 µM; AT1 antagonist) but not by PD123,319 [S-(+)-1-([4-(dimethylamino)-3-methylphenyl]methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo(4,5-c)pyridine-6-carboxylic acid] (0.1 µM; AT2 antagonist). Conversely, the passive relaxation was inhibited (Emax = 18.00 ± 3.45%) by PD123,319 but not by losartan. Ang II (0.3 µM to 100 µM) produced initial contractions (Emax = 11.49 ± 9.39%) followed by active relaxations [Imax (maximum inhibition elicited by the agonist) = 47.85 ± 4.23%] on strips precontracted by bethanechol (100 µM). A second administration of Ang II on the background of bethanechol (1 h later) resulted in stronger relaxations (Imax = 64.03 ± 5.47%) without the initial contractions. NG-Nitro-L-arginine methyl ester [nitric-oxide synthase (NOS) inhibitor], ODQ (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one; guanylate cyclase inhibitor), PD123,319, and tetrodotoxin (neurotoxin) inhibited the relaxations. The presence of AT1 and AT2 receptors was confirmed by Western blot. Experiments with amastatin (1 µM) and thiorphan (1 µM), aminopeptidase, and neutral endopeptidase inhibitors, respectively, excluded the involvement of enzymatic degradation in Ang II-induced relaxation of ASM. In conclusion, the rat ASM relaxation by Ang II is the result of active and passive relaxations. The passive relaxation depends on desensitization of excitatory AT1 receptors, and the active relaxation is mediated by stimulation of AT2 receptors and activation of the neuronal NOS/soluble guanylate cyclase pathway.
Address correspondence to: Dr. Satish Rattan, Jefferson Medical College, Thomas Jefferson University, 1025 Walnut Street, Room # 901 College, Philadelphia, PA 19107. E-mail: satish.rattan{at}jefferson.edu
This article has been cited by other articles:
![]() |
N. Toda, K. Ayajiki, and T. Okamura Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. F. de Godoy and S. Rattan Translocation of AT1- and AT2-Receptors by Higher Concentrations of Angiotensin II in the Smooth Muscle Cells of Rat Internal Anal Sphincter J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1088 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. F. De Godoy and S. Rattan Autocrine regulation of internal anal sphincter tone by renin-angiotensin system: comparison with phasic smooth muscle Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1164 - G1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Andresen, K. Shome, E. K. Jackson, and G. G. Romero AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity Am J Physiol Renal Physiol, April 1, 2005; 288(4): F763 - F770. [Abstract] [Full Text] [PDF] |
||||